CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Basilea Pharmaceutica (BSLN) is a Swiss biopharmaceutical company, founded in 2000 and located in Basel, Switzerland. The company discovers, develops and commercialises innovative pharmaceutical products for fungal and bacterial infections, as well as cancer. Basilea Pharmaceutica owns such brands as Zevtera/Mabelio, Cresemba and Toctino. Since 2004, Basilea Pharmaceutica has been listed on the SIX Swiss Exchange. Follow the Basilea Pharma share price (BSLN) at Capital.com.
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.